nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2E1—type 2 diabetes mellitus	0.109	0.387	CbGaD
Tranylcypromine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.107	0.5	CrCrCtD
Tranylcypromine—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.107	0.5	CrCrCtD
Tranylcypromine—CYP1A2—type 2 diabetes mellitus	0.103	0.369	CbGaD
Tranylcypromine—CYP3A4—type 2 diabetes mellitus	0.0685	0.244	CbGaD
Tranylcypromine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0288	0.0815	CbGbCtD
Tranylcypromine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0152	0.043	CbGbCtD
Tranylcypromine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0148	0.042	CbGbCtD
Tranylcypromine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0136	0.0384	CbGbCtD
Tranylcypromine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0129	0.0365	CbGbCtD
Tranylcypromine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0129	0.0365	CbGbCtD
Tranylcypromine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0126	0.0357	CbGbCtD
Tranylcypromine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0119	0.0337	CbGbCtD
Tranylcypromine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0115	0.0326	CbGbCtD
Tranylcypromine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0311	CbGbCtD
Tranylcypromine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0107	0.0304	CbGbCtD
Tranylcypromine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0107	0.0304	CbGbCtD
Tranylcypromine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0099	0.028	CbGbCtD
Tranylcypromine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00981	0.0278	CbGbCtD
Tranylcypromine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00968	0.0274	CbGbCtD
Tranylcypromine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00956	0.0271	CbGbCtD
Tranylcypromine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00906	0.0256	CbGbCtD
Tranylcypromine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00875	0.0248	CbGbCtD
Tranylcypromine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00865	0.0245	CbGbCtD
Tranylcypromine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00863	0.0244	CbGbCtD
Tranylcypromine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00818	0.0232	CbGbCtD
Tranylcypromine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00813	0.023	CbGbCtD
Tranylcypromine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00789	0.0223	CbGbCtD
Tranylcypromine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0078	0.0221	CbGbCtD
Tranylcypromine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00744	0.021	CbGbCtD
Tranylcypromine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00713	0.0202	CbGbCtD
Tranylcypromine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0069	0.0195	CbGbCtD
Tranylcypromine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00661	0.0187	CbGbCtD
Tranylcypromine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00624	0.0177	CbGbCtD
Tranylcypromine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00604	0.0171	CbGbCtD
Tranylcypromine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00558	0.0158	CbGbCtD
Tranylcypromine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00549	0.0155	CbGbCtD
Tranylcypromine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00502	0.0142	CbGbCtD
Tranylcypromine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00473	0.0134	CbGbCtD
Tranylcypromine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00453	0.0128	CbGbCtD
Tranylcypromine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00453	0.0128	CbGbCtD
Tranylcypromine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00429	0.0121	CbGbCtD
Tranylcypromine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00319	0.00904	CbGbCtD
Tranylcypromine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00292	0.00827	CbGbCtD
Tranylcypromine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000825	0.354	CrCbGaD
Tranylcypromine—Phenelzine—AOC3—type 2 diabetes mellitus	0.000663	0.285	CrCbGaD
Tranylcypromine—MAOB—nerve—type 2 diabetes mellitus	0.000381	0.105	CbGeAlD
Tranylcypromine—MAOA—nerve—type 2 diabetes mellitus	0.000325	0.0892	CbGeAlD
Tranylcypromine—Phenylpropanolamine—ADRA2A—type 2 diabetes mellitus	0.000176	0.0753	CrCbGaD
Tranylcypromine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.00016	0.0438	CbGeAlD
Tranylcypromine—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000158	0.0432	CbGeAlD
Tranylcypromine—MAOB—nephron tubule—type 2 diabetes mellitus	0.000149	0.0408	CbGeAlD
Tranylcypromine—MAOA—retina—type 2 diabetes mellitus	0.000135	0.0369	CbGeAlD
Tranylcypromine—MAOB—cardiovascular system—type 2 diabetes mellitus	0.000134	0.0366	CbGeAlD
Tranylcypromine—MAOB—kidney—type 2 diabetes mellitus	0.000131	0.0358	CbGeAlD
Tranylcypromine—MAOB—cortex of kidney—type 2 diabetes mellitus	0.000127	0.0349	CbGeAlD
Tranylcypromine—MAOA—nephron tubule—type 2 diabetes mellitus	0.000127	0.0348	CbGeAlD
Tranylcypromine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00126	CcSEcCtD
Tranylcypromine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00126	CcSEcCtD
Tranylcypromine—Tremor—Metformin—type 2 diabetes mellitus	0.000122	0.00125	CcSEcCtD
Tranylcypromine—Phenylpropanolamine—CYP1A2—type 2 diabetes mellitus	0.000122	0.0523	CrCbGaD
Tranylcypromine—Sweating—Ramipril—type 2 diabetes mellitus	0.000122	0.00125	CcSEcCtD
Tranylcypromine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000122	0.00125	CcSEcCtD
Tranylcypromine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000121	0.00125	CcSEcCtD
Tranylcypromine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000121	0.00124	CcSEcCtD
Tranylcypromine—Anxiety—Orlistat—type 2 diabetes mellitus	0.00012	0.00123	CcSEcCtD
Tranylcypromine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000119	0.00122	CcSEcCtD
Tranylcypromine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000119	0.00122	CcSEcCtD
Tranylcypromine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000119	0.00122	CcSEcCtD
Tranylcypromine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Tranylcypromine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Tranylcypromine—MAOB—adipose tissue—type 2 diabetes mellitus	0.000118	0.0323	CbGeAlD
Tranylcypromine—Alopecia—Losartan—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Tranylcypromine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000118	0.00121	CcSEcCtD
Tranylcypromine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Syncope—Metformin—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Oedema—Valsartan—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000117	0.0012	CcSEcCtD
Tranylcypromine—Rash—Glipizide—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Tranylcypromine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Tranylcypromine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000116	0.00119	CcSEcCtD
Tranylcypromine—Oedema—Orlistat—type 2 diabetes mellitus	0.000115	0.00119	CcSEcCtD
Tranylcypromine—Headache—Glipizide—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Palpitations—Metformin—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Shock—Valsartan—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000115	0.00118	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Tranylcypromine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Tranylcypromine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Tranylcypromine—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000114	0.0312	CbGeAlD
Tranylcypromine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Tranylcypromine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000114	0.00117	CcSEcCtD
Tranylcypromine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Tranylcypromine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Tranylcypromine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Tranylcypromine—Hypertension—Metformin—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Tranylcypromine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000113	0.00116	CcSEcCtD
Tranylcypromine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Tranylcypromine—CYP2A6—liver—type 2 diabetes mellitus	0.000112	0.0307	CbGeAlD
Tranylcypromine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000112	0.00115	CcSEcCtD
Tranylcypromine—MAOA—kidney—type 2 diabetes mellitus	0.000111	0.0306	CbGeAlD
Tranylcypromine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Tranylcypromine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Tranylcypromine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000111	0.00114	CcSEcCtD
Tranylcypromine—MAOA—pancreas—type 2 diabetes mellitus	0.000111	0.0304	CbGeAlD
Tranylcypromine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Tranylcypromine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Tranylcypromine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.00113	CcSEcCtD
Tranylcypromine—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	0.00011	0.0473	CrCbGaD
Tranylcypromine—Nausea—Glipizide—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.00112	CcSEcCtD
Tranylcypromine—Phentermine—CYP1A2—type 2 diabetes mellitus	0.000109	0.0466	CrCbGaD
Tranylcypromine—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000109	0.0298	CbGeAlD
Tranylcypromine—Tremor—Losartan—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Rash—Glimepiride—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00111	CcSEcCtD
Tranylcypromine—Headache—Glimepiride—type 2 diabetes mellitus	0.000108	0.0011	CcSEcCtD
Tranylcypromine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000107	0.0011	CcSEcCtD
Tranylcypromine—Anaemia—Losartan—type 2 diabetes mellitus	0.000107	0.0011	CcSEcCtD
Tranylcypromine—Agitation—Losartan—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Oedema—Metformin—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Flushing—Ramipril—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000106	0.00109	CcSEcCtD
Tranylcypromine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000105	0.00108	CcSEcCtD
Tranylcypromine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000105	0.00108	CcSEcCtD
Tranylcypromine—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	0.000105	0.045	CrCbGaD
Tranylcypromine—Shock—Metformin—type 2 diabetes mellitus	0.000105	0.00108	CcSEcCtD
Tranylcypromine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Syncope—Losartan—type 2 diabetes mellitus	0.000104	0.00107	CcSEcCtD
Tranylcypromine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Tranylcypromine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000104	0.00106	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000103	0.00106	CcSEcCtD
Tranylcypromine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Tranylcypromine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Tranylcypromine—Palpitations—Losartan—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Tranylcypromine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Tranylcypromine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000102	0.00105	CcSEcCtD
Tranylcypromine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000102	0.00104	CcSEcCtD
Tranylcypromine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000102	0.00104	CcSEcCtD
Tranylcypromine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000102	0.00104	CcSEcCtD
Tranylcypromine—Anorexia—Metformin—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Tranylcypromine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Tranylcypromine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000101	0.00104	CcSEcCtD
Tranylcypromine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Tranylcypromine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000101	0.00103	CcSEcCtD
Tranylcypromine—MAOA—adipose tissue—type 2 diabetes mellitus	0.0001	0.0276	CbGeAlD
Tranylcypromine—Oedema—Irbesartan—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Tranylcypromine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.0001	0.00103	CcSEcCtD
Tranylcypromine—Constipation—Valsartan—type 2 diabetes mellitus	9.99e-05	0.00103	CcSEcCtD
Tranylcypromine—Hypotension—Metformin—type 2 diabetes mellitus	9.94e-05	0.00102	CcSEcCtD
Tranylcypromine—Shock—Irbesartan—type 2 diabetes mellitus	9.88e-05	0.00101	CcSEcCtD
Tranylcypromine—Pain—Orlistat—type 2 diabetes mellitus	9.87e-05	0.00101	CcSEcCtD
Tranylcypromine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.85e-05	0.00101	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.00101	CcSEcCtD
Tranylcypromine—Anxiety—Losartan—type 2 diabetes mellitus	9.83e-05	0.00101	CcSEcCtD
Tranylcypromine—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.00101	CcSEcCtD
Tranylcypromine—Rash—Bromocriptine—type 2 diabetes mellitus	9.77e-05	0.001	CcSEcCtD
Tranylcypromine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.76e-05	0.001	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000997	CcSEcCtD
Tranylcypromine—Headache—Bromocriptine—type 2 diabetes mellitus	9.71e-05	0.000997	CcSEcCtD
Tranylcypromine—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.69e-05	0.000995	CcSEcCtD
Tranylcypromine—Dry mouth—Losartan—type 2 diabetes mellitus	9.64e-05	0.00099	CcSEcCtD
Tranylcypromine—Anorexia—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.000983	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.56e-05	0.000981	CcSEcCtD
Tranylcypromine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.56e-05	0.000981	CcSEcCtD
Tranylcypromine—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.55e-05	0.00098	CcSEcCtD
Tranylcypromine—Confusional state—Losartan—type 2 diabetes mellitus	9.53e-05	0.000979	CcSEcCtD
Tranylcypromine—CYP2E1—nephron tubule—type 2 diabetes mellitus	9.52e-05	0.0261	CbGeAlD
Tranylcypromine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.52e-05	0.000977	CcSEcCtD
Tranylcypromine—Somnolence—Metformin—type 2 diabetes mellitus	9.46e-05	0.000971	CcSEcCtD
Tranylcypromine—Oedema—Losartan—type 2 diabetes mellitus	9.45e-05	0.000971	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.44e-05	0.00097	CcSEcCtD
Tranylcypromine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.38e-05	0.000964	CcSEcCtD
Tranylcypromine—Phenelzine—CYP2E1—type 2 diabetes mellitus	9.31e-05	0.04	CrCbGaD
Tranylcypromine—Tremor—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000955	CcSEcCtD
Tranylcypromine—Shock—Losartan—type 2 diabetes mellitus	9.3e-05	0.000955	CcSEcCtD
Tranylcypromine—Urticaria—Valsartan—type 2 diabetes mellitus	9.28e-05	0.000953	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.25e-05	0.00095	CcSEcCtD
Tranylcypromine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.25e-05	0.00095	CcSEcCtD
Tranylcypromine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.24e-05	0.000949	CcSEcCtD
Tranylcypromine—Tachycardia—Losartan—type 2 diabetes mellitus	9.22e-05	0.000947	CcSEcCtD
Tranylcypromine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.2e-05	0.000945	CcSEcCtD
Tranylcypromine—Urticaria—Orlistat—type 2 diabetes mellitus	9.17e-05	0.000942	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.14e-05	0.000938	CcSEcCtD
Tranylcypromine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000937	CcSEcCtD
Tranylcypromine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000937	CcSEcCtD
Tranylcypromine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.13e-05	0.000937	CcSEcCtD
Tranylcypromine—Agitation—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000937	CcSEcCtD
Tranylcypromine—Constipation—Metformin—type 2 diabetes mellitus	9.1e-05	0.000934	CcSEcCtD
Tranylcypromine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	9.02e-05	0.0247	CbGeAlD
Tranylcypromine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000926	CcSEcCtD
Tranylcypromine—Anorexia—Losartan—type 2 diabetes mellitus	9.01e-05	0.000925	CcSEcCtD
Tranylcypromine—Vomiting—Glyburide—type 2 diabetes mellitus	9.01e-05	0.000925	CcSEcCtD
Tranylcypromine—Rash—Glyburide—type 2 diabetes mellitus	8.93e-05	0.000917	CcSEcCtD
Tranylcypromine—Somnolence—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000917	CcSEcCtD
Tranylcypromine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.92e-05	0.000916	CcSEcCtD
Tranylcypromine—Syncope—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000914	CcSEcCtD
Tranylcypromine—Leukopenia—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000913	CcSEcCtD
Tranylcypromine—Headache—Glyburide—type 2 diabetes mellitus	8.87e-05	0.000911	CcSEcCtD
Tranylcypromine—Hypotension—Losartan—type 2 diabetes mellitus	8.83e-05	0.000907	CcSEcCtD
Tranylcypromine—Palpitations—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000901	CcSEcCtD
Tranylcypromine—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.77e-05	0.000901	CcSEcCtD
Tranylcypromine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000896	CcSEcCtD
Tranylcypromine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000896	CcSEcCtD
Tranylcypromine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.7e-05	0.000894	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.7e-05	0.000894	CcSEcCtD
Tranylcypromine—Constipation—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000882	CcSEcCtD
Tranylcypromine—Pain—Irbesartan—type 2 diabetes mellitus	8.59e-05	0.000882	CcSEcCtD
Tranylcypromine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	8.55e-05	0.0235	CbGeAlD
Tranylcypromine—Insomnia—Losartan—type 2 diabetes mellitus	8.55e-05	0.000878	CcSEcCtD
Tranylcypromine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.49e-05	0.000871	CcSEcCtD
Tranylcypromine—Urticaria—Metformin—type 2 diabetes mellitus	8.45e-05	0.000868	CcSEcCtD
Tranylcypromine—Anxiety—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000865	CcSEcCtD
Tranylcypromine—Nausea—Glyburide—type 2 diabetes mellitus	8.41e-05	0.000864	CcSEcCtD
Tranylcypromine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.41e-05	0.000864	CcSEcCtD
Tranylcypromine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.41e-05	0.000864	CcSEcCtD
Tranylcypromine—Somnolence—Losartan—type 2 diabetes mellitus	8.4e-05	0.000863	CcSEcCtD
Tranylcypromine—Asthenia—Valsartan—type 2 diabetes mellitus	8.38e-05	0.000861	CcSEcCtD
Tranylcypromine—CYP2E1—kidney—type 2 diabetes mellitus	8.37e-05	0.0229	CbGeAlD
Tranylcypromine—Asthenia—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000851	CcSEcCtD
Tranylcypromine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.00085	CcSEcCtD
Tranylcypromine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000849	CcSEcCtD
Tranylcypromine—MAOB—liver—type 2 diabetes mellitus	8.26e-05	0.0227	CbGeAlD
Tranylcypromine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.22e-05	0.000844	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000843	CcSEcCtD
Tranylcypromine—Confusional state—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000839	CcSEcCtD
Tranylcypromine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	8.15e-05	0.0223	CbGeAlD
Tranylcypromine—Oedema—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000832	CcSEcCtD
Tranylcypromine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.00083	CcSEcCtD
Tranylcypromine—Constipation—Losartan—type 2 diabetes mellitus	8.08e-05	0.00083	CcSEcCtD
Tranylcypromine—Pain—Losartan—type 2 diabetes mellitus	8.08e-05	0.00083	CcSEcCtD
Tranylcypromine—Rash—Gliclazide—type 2 diabetes mellitus	8.02e-05	0.000824	CcSEcCtD
Tranylcypromine—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.01e-05	0.000823	CcSEcCtD
Tranylcypromine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8e-05	0.000821	CcSEcCtD
Tranylcypromine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.98e-05	0.000819	CcSEcCtD
Tranylcypromine—Shock—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000819	CcSEcCtD
Tranylcypromine—Headache—Gliclazide—type 2 diabetes mellitus	7.97e-05	0.000818	CcSEcCtD
Tranylcypromine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000815	CcSEcCtD
Tranylcypromine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000815	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000815	CcSEcCtD
Tranylcypromine—Tachycardia—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000812	CcSEcCtD
Tranylcypromine—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.9e-05	0.000811	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000804	CcSEcCtD
Tranylcypromine—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.79e-05	0.0008	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.73e-05	0.000794	CcSEcCtD
Tranylcypromine—Dizziness—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000794	CcSEcCtD
Tranylcypromine—Anorexia—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000793	CcSEcCtD
Tranylcypromine—Dizziness—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000784	CcSEcCtD
Tranylcypromine—Asthenia—Metformin—type 2 diabetes mellitus	7.64e-05	0.000784	CcSEcCtD
Tranylcypromine—Hypotension—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000778	CcSEcCtD
Tranylcypromine—Nausea—Gliclazide—type 2 diabetes mellitus	7.56e-05	0.000776	CcSEcCtD
Tranylcypromine—Urticaria—Losartan—type 2 diabetes mellitus	7.51e-05	0.000771	CcSEcCtD
Tranylcypromine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.47e-05	0.000767	CcSEcCtD
Tranylcypromine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.47e-05	0.000767	CcSEcCtD
Tranylcypromine—Vomiting—Valsartan—type 2 diabetes mellitus	7.43e-05	0.000763	CcSEcCtD
Tranylcypromine—Rash—Valsartan—type 2 diabetes mellitus	7.37e-05	0.000757	CcSEcCtD
Tranylcypromine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.36e-05	0.000756	CcSEcCtD
Tranylcypromine—Vomiting—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000754	CcSEcCtD
Tranylcypromine—Insomnia—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000753	CcSEcCtD
Tranylcypromine—Headache—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000752	CcSEcCtD
Tranylcypromine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.28e-05	0.000748	CcSEcCtD
Tranylcypromine—Rash—Orlistat—type 2 diabetes mellitus	7.28e-05	0.000748	CcSEcCtD
Tranylcypromine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000747	CcSEcCtD
Tranylcypromine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.27e-05	0.000747	CcSEcCtD
Tranylcypromine—Headache—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000743	CcSEcCtD
Tranylcypromine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.00074	CcSEcCtD
Tranylcypromine—Somnolence—Ramipril—type 2 diabetes mellitus	7.2e-05	0.00074	CcSEcCtD
Tranylcypromine—CYP2C19—liver—type 2 diabetes mellitus	7.2e-05	0.0197	CbGeAlD
Tranylcypromine—MAOA—liver—type 2 diabetes mellitus	7.05e-05	0.0193	CbGeAlD
Tranylcypromine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000723	CcSEcCtD
Tranylcypromine—Dizziness—Metformin—type 2 diabetes mellitus	7.04e-05	0.000723	CcSEcCtD
Tranylcypromine—Nausea—Valsartan—type 2 diabetes mellitus	6.94e-05	0.000713	CcSEcCtD
Tranylcypromine—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	6.94e-05	0.0298	CrCbGaD
Tranylcypromine—Constipation—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000712	CcSEcCtD
Tranylcypromine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000706	CcSEcCtD
Tranylcypromine—Nausea—Orlistat—type 2 diabetes mellitus	6.86e-05	0.000704	CcSEcCtD
Tranylcypromine—Asthenia—Losartan—type 2 diabetes mellitus	6.78e-05	0.000696	CcSEcCtD
Tranylcypromine—Vomiting—Metformin—type 2 diabetes mellitus	6.77e-05	0.000695	CcSEcCtD
Tranylcypromine—CYP3A4—kidney—type 2 diabetes mellitus	6.73e-05	0.0185	CbGeAlD
Tranylcypromine—Rash—Metformin—type 2 diabetes mellitus	6.71e-05	0.000689	CcSEcCtD
Tranylcypromine—Dermatitis—Metformin—type 2 diabetes mellitus	6.7e-05	0.000688	CcSEcCtD
Tranylcypromine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000686	CcSEcCtD
Tranylcypromine—Headache—Metformin—type 2 diabetes mellitus	6.67e-05	0.000685	CcSEcCtD
Tranylcypromine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000682	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.63e-05	0.00068	CcSEcCtD
Tranylcypromine—CYP2D6—kidney—type 2 diabetes mellitus	6.63e-05	0.0182	CbGeAlD
Tranylcypromine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.47e-05	0.000664	CcSEcCtD
Tranylcypromine—Urticaria—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000661	CcSEcCtD
Tranylcypromine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000658	CcSEcCtD
Tranylcypromine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000658	CcSEcCtD
Tranylcypromine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000656	CcSEcCtD
Tranylcypromine—Rash—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.00065	CcSEcCtD
Tranylcypromine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.00065	CcSEcCtD
Tranylcypromine—Nausea—Metformin—type 2 diabetes mellitus	6.32e-05	0.000649	CcSEcCtD
Tranylcypromine—Headache—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000646	CcSEcCtD
Tranylcypromine—Dizziness—Losartan—type 2 diabetes mellitus	6.25e-05	0.000642	CcSEcCtD
Tranylcypromine—Vomiting—Losartan—type 2 diabetes mellitus	6.01e-05	0.000617	CcSEcCtD
Tranylcypromine—Nausea—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000613	CcSEcCtD
Tranylcypromine—Rash—Losartan—type 2 diabetes mellitus	5.96e-05	0.000612	CcSEcCtD
Tranylcypromine—Dermatitis—Losartan—type 2 diabetes mellitus	5.95e-05	0.000611	CcSEcCtD
Tranylcypromine—Headache—Losartan—type 2 diabetes mellitus	5.92e-05	0.000608	CcSEcCtD
Tranylcypromine—CYP1A2—liver—type 2 diabetes mellitus	5.88e-05	0.0161	CbGeAlD
Tranylcypromine—Phenelzine—CYP3A4—type 2 diabetes mellitus	5.86e-05	0.0252	CrCbGaD
Tranylcypromine—Asthenia—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000597	CcSEcCtD
Tranylcypromine—Nausea—Losartan—type 2 diabetes mellitus	5.61e-05	0.000576	CcSEcCtD
Tranylcypromine—CYP2C9—liver—type 2 diabetes mellitus	5.58e-05	0.0153	CbGeAlD
Tranylcypromine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000569	CcSEcCtD
Tranylcypromine—Dizziness—Ramipril—type 2 diabetes mellitus	5.36e-05	0.00055	CcSEcCtD
Tranylcypromine—CYP2E1—liver—type 2 diabetes mellitus	5.29e-05	0.0145	CbGeAlD
Tranylcypromine—Vomiting—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000529	CcSEcCtD
Tranylcypromine—Rash—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000525	CcSEcCtD
Tranylcypromine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000524	CcSEcCtD
Tranylcypromine—Headache—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000521	CcSEcCtD
Tranylcypromine—Nausea—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000494	CcSEcCtD
Tranylcypromine—CYP3A4—liver—type 2 diabetes mellitus	4.26e-05	0.0117	CbGeAlD
Tranylcypromine—CYP2D6—liver—type 2 diabetes mellitus	4.19e-05	0.0115	CbGeAlD
Tranylcypromine—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.02e-06	8.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4e-06	8.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.98e-06	8.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	3.96e-06	8.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.95e-06	7.99e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	3.94e-06	7.99e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ALB—type 2 diabetes mellitus	3.91e-06	7.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	3.89e-06	7.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	3.88e-06	7.85e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.87e-06	7.83e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	3.83e-06	7.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	3.83e-06	7.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.81e-06	7.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.81e-06	7.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.81e-06	7.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.79e-06	7.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.79e-06	7.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.78e-06	7.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.78e-06	7.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.78e-06	7.66e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.77e-06	7.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.75e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.75e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.74e-06	7.58e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	3.74e-06	7.58e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	3.74e-06	7.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	3.73e-06	7.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.71e-06	7.51e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.71e-06	7.51e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.7e-06	7.48e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.7e-06	7.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.68e-06	7.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.66e-06	7.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	3.66e-06	7.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.64e-06	7.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.63e-06	7.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.63e-06	7.34e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.62e-06	7.34e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.62e-06	7.34e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.6e-06	7.3e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.6e-06	7.29e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.6e-06	7.29e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.6e-06	7.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.6e-06	7.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.6e-06	7.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.6e-06	7.28e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.58e-06	7.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.58e-06	7.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.57e-06	7.22e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.52e-06	7.12e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.5e-06	7.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.5e-06	7.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.5e-06	7.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.5e-06	7.09e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.49e-06	7.06e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.48e-06	7.04e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.47e-06	7.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.46e-06	7e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.45e-06	6.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.45e-06	6.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.43e-06	6.95e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	3.42e-06	6.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.42e-06	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.42e-06	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	3.38e-06	6.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.36e-06	6.81e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.36e-06	6.79e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.33e-06	6.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.32e-06	6.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	3.31e-06	6.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.31e-06	6.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.31e-06	6.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-06	6.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.28e-06	6.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.28e-06	6.64e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.24e-06	6.56e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.23e-06	6.54e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.23e-06	6.54e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.23e-06	6.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.23e-06	6.54e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.17e-06	6.42e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.14e-06	6.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.13e-06	6.33e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.12e-06	6.32e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.1e-06	6.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.1e-06	6.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.1e-06	6.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.08e-06	6.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	6.23e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.08e-06	6.23e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	6.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.04e-06	6.16e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.04e-06	6.15e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-06	6.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.96e-06	5.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.95e-06	5.98e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.92e-06	5.92e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.91e-06	5.9e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-06	5.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-06	5.88e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.87e-06	5.82e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.85e-06	5.78e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.85e-06	5.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.85e-06	5.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.85e-06	5.77e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.85e-06	5.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.84e-06	5.74e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.83e-06	5.74e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.83e-06	5.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.83e-06	5.72e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.82e-06	5.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.81e-06	5.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.8e-06	5.67e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.8e-06	5.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.8e-06	5.67e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.8e-06	5.66e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.78e-06	5.63e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.78e-06	5.63e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.78e-06	5.63e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.78e-06	5.62e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.76e-06	5.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-06	5.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.75e-06	5.57e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	2.74e-06	5.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.72e-06	5.5e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.71e-06	5.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.69e-06	5.45e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.68e-06	5.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.68e-06	5.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-06	5.41e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-06	5.38e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.65e-06	5.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.64e-06	5.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.62e-06	5.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.62e-06	5.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.59e-06	5.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	5.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.54e-06	5.14e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.54e-06	5.14e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.53e-06	5.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.52e-06	5.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.51e-06	5.08e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.49e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.49e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.49e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.47e-06	4.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.45e-06	4.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.44e-06	4.95e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.43e-06	4.93e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.43e-06	4.91e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-06	4.89e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-06	4.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	4.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.41e-06	4.89e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-06	4.87e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.4e-06	4.86e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.37e-06	4.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.37e-06	4.81e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.37e-06	4.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.36e-06	4.79e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.34e-06	4.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.34e-06	4.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.32e-06	4.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.3e-06	4.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	4.65e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	4.65e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.29e-06	4.64e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.28e-06	4.62e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	4.6e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.26e-06	4.57e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.26e-06	4.57e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.24e-06	4.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.22e-06	4.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	4.46e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.2e-06	4.45e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.18e-06	4.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.18e-06	4.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	4.38e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.16e-06	4.38e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.16e-06	4.38e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.16e-06	4.37e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-06	4.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.15e-06	4.35e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-06	4.34e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	4.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	4.25e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.09e-06	4.23e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-06	4.18e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.06e-06	4.17e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.02e-06	4.09e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.98e-06	4.01e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-06	3.93e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.89e-06	3.84e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.88e-06	3.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	3.8e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.86e-06	3.77e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.86e-06	3.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.86e-06	3.76e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.85e-06	3.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.85e-06	3.75e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.85e-06	3.74e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.84e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.83e-06	3.71e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	3.69e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.78e-06	3.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-06	3.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-06	3.59e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.73e-06	3.5e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	1.72e-06	3.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.7e-06	3.45e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.7e-06	3.44e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	3.42e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.66e-06	3.36e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.66e-06	3.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	3.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	3.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	3.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.62e-06	3.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.62e-06	3.27e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.61e-06	3.26e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	3.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.59e-06	3.22e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	3.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.53e-06	3.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.5e-06	3.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	3.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	2.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.45e-06	2.94e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	2.92e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.43e-06	2.89e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.42e-06	2.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.41e-06	2.85e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	2.8e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	2.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	2.7e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	2.56e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.24e-06	2.51e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.21e-06	2.46e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.11e-06	2.26e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.07e-06	2.16e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.07e-06	2.16e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	2.14e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.74e-07	1.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.14e-07	1.65e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.49e-07	1.52e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.43e-07	1.5e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.35e-07	1.28e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.9e-07	9.92e-06	CbGpPWpGaD
